From the Jerome Lipper Multiple Myeloma Center Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and the Institut National de la Santé et de la Recherche Médicale (INSERM) U0601, Institut de biologie and Service d'hématologie clinique, Hôtel-Dieu Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France. (2004-11-01時点)